Intra-Cellular Therapies To Present Top-Line Results From ITI-214 Phase 1/2 Clinical Trial In Patients With Parkinson's Disease At 2018 American Neurological Association Annual Meeting. Oct. 21-24
Benzinga_Newsdesk